Anogenital cutaneous Crohn's disease: effective treatment with interleukin-23 p19 inhibition in an under-recognized clinical entity.
Saved in:
| Title: | Anogenital cutaneous Crohn's disease: effective treatment with interleukin-23 p19 inhibition in an under-recognized clinical entity. |
|---|---|
| Authors: | Colwill M; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.; Institute of Infection and Immunity, University of London, City St George's, London, United Kingdom., Spencer A; Department of Dermatology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Honap S; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.; School of Immunology and Microbial Sciences, King's College London, London, United Kingdom. |
| Source: | Journal of Crohn's & colitis [J Crohns Colitis] 2026 Apr 08; Vol. 20 (4). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium: Internet ISSN: 1876-4479 (Electronic) Linking ISSN: 18739946 NLM ISO Abbreviation: J Crohns Colitis Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
